Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Hydrolysis, Ligand Exchange, and Redox Properties of Vanadium Compounds: Implications of Solution Transformation on Biological, Therapeutic, and Environmental …
R Dinda, E Garribba, D Sanna, DC Crans… - Chemical …, 2025 - ACS Publications
Vanadium is a transition metal with important industrial, technological, biological, and
biomedical applications widespread in the environment and in living beings. The different …
biomedical applications widespread in the environment and in living beings. The different …
Water-soluble dioxidovanadium (V) complexes of aroylhydrazones: DNA/BSA interactions, hydrophobicity, and cell-selective anticancer potential
G Sahu, A Banerjee, R Samanta, M Mohanty… - Inorganic …, 2021 - ACS Publications
Five new anionic aqueous dioxidovanadium (V) complexes,[{VO2L1, 2} A (H2O) n] α (1–5),
with the aroylhydrazone ligands pyridine-4-carboxylic acid (3-ethoxy-2-hydroxybenzylidene) …
with the aroylhydrazone ligands pyridine-4-carboxylic acid (3-ethoxy-2-hydroxybenzylidene) …
Ruthenium (II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death
G Sahu, SA Patra, S Lima, S Das… - … A European Journal, 2023 - Wiley Online Library
The reaction of the Ru (PPh3) 3Cl2 with HL1− 3− OH (− OH stands for the oxime hydroxyl
group; HL1− OH= diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2− OH …
group; HL1− OH= diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2− OH …
Vanadium (IV) complexes of salicylaldehyde-based furoic acid hydrazones: Synthesis, BSA binding and in vivo antidiabetic potential
A Zahirović, S Hadžalić, A Višnjevac, M Fočak… - Journal of inorganic …, 2023 - Elsevier
Solution synthesis afforded five novel neutral heteroleptic octahedral paramagnetic
mononuclear oxidovanadium (IV) complexes of general composition [VO (bpy) L], where L is …
mononuclear oxidovanadium (IV) complexes of general composition [VO (bpy) L], where L is …
Structure and biological properties of mixed-ligand Cu (II) Schiff base complexes as potential anticancer agents
Y Gou, J Li, B Fan, B Xu, M Zhou, F Yang - European Journal of Medicinal …, 2017 - Elsevier
We synthesized two mixed-ligand Cu (II) complexes containing different aroylhydrazone
ligands and a pyridine co-ligand, namely,[Cu (L1)(Py)](C1) and [Cu (L2)(Py)(Br)](C2)(L1=(E) …
ligands and a pyridine co-ligand, namely,[Cu (L1)(Py)](C1) and [Cu (L2)(Py)(Br)](C2)(L1=(E) …
LVVO-Ethyl Maltol-Based Metallodrugs (L2– = Tridentate ONO Ligands): Hydrophobicity, Hydrolytic Stability, and Cytotoxicity via ROS-Mediated Apoptosis
G Sahu, SA Patra, PD Pattanayak… - Inorganic …, 2023 - ACS Publications
Four new oxidovanadium [VVOL1–4 (ema)] complexes (1–4) have been synthesized using
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …
Polynuclear zinc (II) complexes of thiosemicarbazone: Synthesis, X-ray structure and biological evaluation
M Mohanty, A Banerjee, S Biswal, A Horn Jr… - Journal of Inorganic …, 2020 - Elsevier
Two new dimeric Zn (II)([{ZnL 1 (DMSO 2)} 2]· DMSO (1),[{ZnL 2 Cl} 2](2)) and a novel
tetrameric Zn (II) complex ([(Zn 2 L 3) 2 (μ–OAc) 2 (μ 3–O) 2](3)), where H 2 L 1= 4–(p …
tetrameric Zn (II) complex ([(Zn 2 L 3) 2 (μ–OAc) 2 (μ 3–O) 2](3)), where H 2 L 1= 4–(p …
Moderate DNA and high SARS-CoV-2 spike protein affinity of oxidovanadium (IV) complexes of 2-furoic acid hydrazones: In silico and in vitro approach
A Zahirović, B Tüzün, S Hadžalić, I Osmanković… - Journal of molecular …, 2023 - Elsevier
The interaction of five neutral heteroleptic octahedral paramagnetic mononuclear
oxidovanadium (IV) complexes of general composition [V IV O (bpy) L], where L is a …
oxidovanadium (IV) complexes of general composition [V IV O (bpy) L], where L is a …
Fluorescent diorganotin (IV) complexes as anticancer agents: study of cytotoxicity, cellular localization, and mechanism of cell death
SA Patra, G Sahu, D Mohapatra, PD Pattanayak… - …, 2023 - ACS Publications
Three luminescent mixed ligand diorganotin (IV) complexes [Sn2Ph4 (L) 1–3 (DPA)(MeOH)
Cl](where L1=(Z)-N-((E)-3-ethoxy-2-hydroxybenzylidene) isonicotinohydrazonic acid, L2=(Z) …
Cl](where L1=(Z)-N-((E)-3-ethoxy-2-hydroxybenzylidene) isonicotinohydrazonic acid, L2=(Z) …
A Series of Non-Oxido VIV Complexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity
A Banerjee, SA Patra, G Sahu, G Sciortino… - Inorganic …, 2023 - ACS Publications
A series of mononuclear non-oxido vanadium (IV) complexes,[VIV (L1–4) 2](1–4), featuring
tridentate bi-negative ONS chelating S-alkyl/aryl-substituted dithiocarbazate ligands H2L1 …
tridentate bi-negative ONS chelating S-alkyl/aryl-substituted dithiocarbazate ligands H2L1 …